Iași, February 15, 2022: Vetro Solutions, a Romanian company, specialised in the distribution of pharmaceuticals and services dedicated to veterinary medicine, consolidates its business in terms of development strategy and managerial expertise by becoming a Joint Stock Company (SA) and appointing a Board of Directors run by the founder Dumitru Fodor and comprising five members with a two-year term.
The management team of Vetro is represented on the Board by Coca Cașcaval, CEO of Vetro Solutions, with over 20 years of experience in management, business strategy and company development, Cătălin Ionel Vrabie, deputy CEO within Vetro Solutions. The company included two other non-executive professionals in the BD: Dragoș Lucian Dinu, with relevant experience in the administration of companies such as A&D Pharma or Țiriac Holdings and Marius Leonard Gherghina, specialised in investments and business strategy, involved in development projects for entrepreneurial businesses such as MedLife.
Due to the new changes and company development strategy, Vetro estimates that this year (to consolidate business), it will maintain the rhythm of income increase by 15%, similar to 2021. Whereas in 2021, Vetro focused on investment, in 2022, one of the primary objectives is team development and consolidation.
One year ago, we undertook the mission of becoming the changing vector in the Romanian veterinary market. From 2022, Vetro Solutions has turned from an LLC (Limited Liability Company) into a Joint Stock Company. We have also decided for the development, investments, and corporate governance strategy to be approved by a Board of Directors. The board comprises three professionals who bring their expertise and objectivity (besides their great insight into the economic environment). We are happy to announce that the CEO of Vetro, Coca Cașcaval (one of the most experienced managers in the pharma industry), has been joined by non-executive professionals with similar expertise: Dragoș Lucian Dinu and Marius Leonard Gherghina. I am persuaded that we will achieve a higher company development level together and that we will implement the corporate governance and transparency principles in our relationship with the business community
according to Dumitru Fodor, founder and president of the Vetro Solutions Board of Directors.
Among the objectives of the newly-founded Board of Directors, we mention an increase in investment process effectiveness and the identification of new investment opportunities. There are already two ongoing investment projects at Vetro (in the implementation phase).
Turning into a Joint Stock Company is the natural step for our company to enter a new development phase. It is the best argument to support the success strategy on which Vetro has relied its evolution from the beginning. The role undertaken by our company in the Romanian market is closely connected to the finalisation of the two investment projects begun a few years ago, supporting company development and team consolidation. We have taken on a courageous but realistic approach. Hence, for this year (still dominated by unpredictability), we wish to maintain the evolution rhythm of the previous year. The strategy for 2022 considers a 15% income increase, as in 2021; we also forecast the operationalisation of the two major investment projects,
according to Coca Cașcaval, CEO of Vetro and BD member.
Founded in 2012 by the veterinarian Dumitru Fodor, Vetro Solutions has doubled its income within the last four years. Hence, it has become a top player in the market of veterinary products and services due to national expansion and strategic partnerships with global giants in the field (i.e., Ceva, Richter Pharma, MSD, etc.).
In 2021, Vetro was granted the operating license for its factory in Iași, a production unit built following the highest pharmaceutical industry standards. The project (with an estimated value of 4.5 million euros) is co-funded by European funds and internal resources. In 2021, the company also launched the adVET brand; under this name, it will produce veterinary pharmaceuticals in Iași. The company will be launching a platform serving veterinary practices and pet owners alike. Its role is to help the community of veterinarians accelerate the development of their businesses.
Vetro Solutions is an exclusively Romanian entrepreneurial endeavour founded in 2012 by veterinarian Dumitru Fodor. It specialises in the import and distribution of pharmaceuticals and services for veterinary practices, and it is organised in two divisions: Vet – for veterinary practices, clinics and pharmacies, and Farms – for physicians and farm owners.
In 2020, Vetro underwent a comprehensive repositioning and rebranding process. Thus, the company has redefined its development ambitions, taking on the role of a changing vector in the Romanian veterinary market.
By inaugurating the production line of Iași in 2022, the company has become a producer of generic pharmaceuticals for veterinary use by launching the adVet brand. In the medium run, Vetro aims to double its income and become the first option for veterinarians thanks to the investments to be finalised and to business consolidation.
The company provides over 3,500 products for the owners of pets and farm animals and consultancy services for veterinarians; thus, it serves over 1,900 unique customers. Its team comprises 85 specialists (most of them graduates of the Veterinarian Medicine Faculty). Based on their certified professional expertise, they provide the best options for the health of both pets and farm animals.
Telefon:
+40 754 993 171
Contact:
[email protected] [email protected] [email protected]
© 2020-2022 All Rights Reserved Vetro